Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4501–4550 of 18633
As of the Effective Date, Toby Williams will be the Company’s sole Chief Executive Officer and principal executive officer.
On July 31, 2024, the Board of Directors (the “ Board ”) of OneSpan Inc. (the “ Company ”) appointed Victor Limongelli as President and Chief Executive Officer, effective immediately.
On July 15, 2024, the Board of Directors (the “Board”) of Phio Pharmaceuticals Corp. (the “Company”) approved the appointment of Robert M. Infarinato to serve as the Company’s Vice President, Chief Financial Officer and designated him as the Company’s principal financial officer and principal accounting officer, effective as of August 1, 2024.
On August 1, 2024, Aaron Speach resigned as the Company’s Chief Executive Officer and President, and Matthew Lourie resigned as the Company’s Chief Financial Officer.
On August 1, 2024, Aaron Speach resigned as the Company’s Chief Executive Officer and President, and Matthew Lourie resigned as the Company’s Chief Financial Officer.
On August 1, 2024, the Company and Mr. Garis entered into an employment agreement (the “Garis Employment Agreement”) providing for Mr. Garis’ appointment as Executive Vice President, Chief Financial Officer and Treasurer of the Company on the Transition Date.
On July 31, 2024, the Board of Directors of the Company appointed Erik Weaver to the role of Executive Vice President & Chief Financial Officer, effective August 1, 2024.
Mr. Ortberg succeeds David L. Calhoun, who on July 30, 2024 tendered his resignation as President and Chief Executive Officer and as a director, effective as of the Transition Date.
On July 30, 2024, the Board of Directors (the “Board”) of The Boeing Company (the “Company”) elected Robert K. (Kelly) Ortberg to serve as President and Chief Executive Officer and as a member of the Board, in each case effective as of August 8, 2024
On July 31, 2024, Simpson Manufacturing Co, Inc. (the “Company”) issued a press release announcing that on July 25, 2024, Brian Magstadt, Chief Financial Officer and Treasurer, notified the Company that he will retire from the Company effective December 31, 2024.
On July 30, 2024, SmartRent, Inc. (the “Company”) announced the departure of Lucas Haldeman, the Company’s Chief Executive Officer (“CEO”) and Chairperson of the Company’s Board of Directors (the “Board”) effective July 29, 2024.
On July 26, 2024, Lucy To, 38, was appointed Chief Financial Officer of SAB Biotherapeutics, Inc., a Delaware corporation (“SAB BIO” or the “Company”), with a start date of August 12, 2024.
On July 30, 2024, the Board of Directors (the “Board”) of the Company appointed Jeffrey Kuehling to serve as Executive Vice President, Chief Financial Officer, effective on a date on or before September 3, 2024, to be mutually agreed between Mr. Kuehling and the Company (the “Transition Date”).
On July 26, 2024, Jeffrey Black resigned as the Senior Vice President and Chief Financial Officer (serving as the principal financial and accounting officer) of Standard BioTools Inc. (the “Company”), effective as of August 31, 2024.
On July 30, 2024, the Company’s Board of Directors appointed Alex Kim, the Company’s Chief Operating Officer, to serve as Interim Chief Financial Officer of the Company, starting on September 1, 2024, to succeed Mr. Black while the Company searches for a permanent Chief Financial Officer.
On July 25, 2024, Rachel Glaser, Etsy’s Chief Financial Officer, notified Etsy that she has decided to retire.
(ii) David Bowler, 46, currently the Company’s Senior Vice President, Deputy Chief Financial Officer and Treasurer, to serve as the Company’s Executive Vice President and Chief Financial Officer, and its principal financial officer.
As of August 1, 2024, M. Susan Hardwick’s officer title will change from President and Chief Executive Officer, to Chief Executive Officer, and she will remain the Company’s principal executive officer and a member of the Board.
On July 31, 2024, Energy Recovery, Inc. (the “Company”) announced the hiring of Mr. Michael Mancini, age 43, as the Chief Financial Officer (“CFO”) of the Company.
Additionally, Mark Pomeranz resigned from his role as Chief Executive Officer of the Company.
David P. Johnson, age 57, will replace Mr. Anderson as executive vice president and chief financial officer effective September 16, 2024.
David J. Anderson, executive vice president and chief financial officer, notified the Company on July 26, 2024, of his intent to retire effective September 16, 2024.
On July 30, 2024, the Board appointed Craig R. Jalbert, age 62, as the Company’s President, Chief Executive Officer, Secretary, Treasurer, and sole member of the Board, effective July 31, 2024.
In connection with the Reduction in Force, Scott B. Brown, CPA, Chief Financial Officer and Secretary will cease serving as an officer of the Company effective July 31, 2024.
On July 30, 2024, Charles P. Theuer, M.D., Ph.D., tendered his resignation as the Company’s President and Chief Executive Officer, to be effective as of July 31, 2024.
his intended successor, Edward Cooper Werner, the Company’s current Senior Vice President of Finance, who is slated to be appointed upon Mr. Pelzer’s retirement.
On July 26, 2024, Frank Pelzer, Executive Vice President and Chief Financial Officer of F5, Inc. (the “Company”), informed the Company of his plans to retire during the Company’s first fiscal quarter 2025, which ends December 31, 2024.
Christopher S. Sotos informed Clearway Energy, Inc. (“ Clearway, Inc. ”), the parent company of the Company, on April 30, 2024 that, effective as of June 30, 2024, he will move on from his position as President and Chief Executive Officer of Clearway, Inc. and the Company.
On July 30, 2024 Hudson Technologies, Inc. (the “Company”) appointed Brian J. Bertaux as its Vice President, Chief Financial Officer and Secretary.
Simultaneously, on such date, Nat Krishnamurti stepped down, effective immediately, from his positions as Vice President, Chief Financial Officer and Secretary of the Company.
Philip Bacchus, who will serve as SVP, Chief Financial Officer effective August 26, 2024, will participate in the Change in Control Plan at Tier 2
On July 25, 2024, the Board appointed Adam Wyll, the Company’s President and Chief Operating Officer, to fill the role of Chief Executive Officer at the Company effective January 1, 2025.
On July 24, 2024, the Board of Directors (the “Board”) of the Company approved the appointment of Kevin Strange as the Chief Financial Officer of the Company as of the Effective Date, succeeding Mr. Hill.
On July 24, 2024, Mitch Hill notified Inari Medical, Inc. (the “Company”) of his decision to retire as Chief Financial Officer of the Company, effective as of October 1, 2024 (the “Effective Date”).
(ii) Steven T. Gallagher, currently the Company’s Senior Vice President, Chief Accounting Officer, and interim Chief Financial Officer and Treasurer, to Executive Vice President, Chief Financial Officer and Treasurer,
Christopher Meinerz, the Company’s Chief Financial Officer, notified Kent Wilson, the Company’s Chief Executive Officer, and the Board of Directors (the “Board”) that Mr. Meinerz intends to resign as the Company’s Chief Financial Officer effective on or by August 30, 2024.
appointed Ginger Smith, currently serving as the Company’s Corporate Controller, to serve as interim Chief Financial Officer until the company hires a permanent replacement.
On July 26, 2024, the Board of Directors elected Benjamin J. Tisch as President and Chief Executive Officer of the Corporation, effective January 1, 2025.
The Board appointed Kendra Bracken-Ferguson as Chief Executive Officer of the Company effective as of July 30, 2024.
Dr. Vignola’s continued service as Chief Financial Officer for a transition period until the date of his separation from employment (the “Vignola Separation Date”), anticipated to be February 1, 2025.
The Board terminated Mr. Matosevic as President, Chief Executive Officer and Board member without severance for cause, per his employment agreement.
As previously disclosed, on June 3, 2024, Amarin Corporation plc (the “Company”) announced that Aaron Berg was appointed to the role of President and Chief Executive Officer (and principal executive officer) of the Company, effective June 4, 2024
the Board of Directors of the Company has appointed Tim Foote, age 44, to replace Mr. Rai as CFO with effect as of July 29, 2024.
Steve Rai, the Company’s Chief Financial Officer (“CFO”), intends to leave the Company to pursue other opportunities
The Champi Employment Agreement contemplates that Peoples and Peoples Bank will promote Mr. Champi to the position of Chief Executive Officer on or prior to July 1, 2025.
the Company’s board of directors (the “Board”) appointed Malte Peters, M.D., as the Company’s Chief Executive Officer and President, effective July 22, 2024.
On July 22, 2024, Reinhard Kandera separated as the Chief Financial Officer of the Company.
On July 22, 2024, Joern Aldag separated as the Chief Executive Officer of HOOKIPA Pharma Inc. (the “Company”).
On July 22, 2024, Alexander Hornung resigned as Chief Financial Officer of Mountain & Co. I Acquisition Corp.
Brad Tade, former Vice President, Financial Operations of ADMA Biologics, Inc. (the "Company"), was promoted to Chief Financial Officer and Treasurer of the Company
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.